0001209191-23-043137.txt : 20230721
0001209191-23-043137.hdr.sgml : 20230721
20230721170850
ACCESSION NUMBER: 0001209191-23-043137
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230719
FILED AS OF DATE: 20230721
DATE AS OF CHANGE: 20230721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JIMENEZ JOSEPH
CENTRAL INDEX KEY: 0001199095
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40532
FILM NUMBER: 231103120
MAIL ADDRESS:
STREET 1: ADITUM BIO
STREET 2: 1111 BROADWAY, STE. 1300
CITY: OAKLAND
STATE: CA
ZIP: 94607
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Graphite Bio, Inc.
CENTRAL INDEX KEY: 0001815776
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 844867570
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 HASKINS WAY, SUITE 210
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 484-0886
MAIL ADDRESS:
STREET 1: 201 HASKINS WAY, SUITE 210
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Integral Medicines, Inc.
DATE OF NAME CHANGE: 20200622
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-07-19
0
0001815776
Graphite Bio, Inc.
GRPH
0001199095
JIMENEZ JOSEPH
C/O GRAPHITE BIO, INC.
201 HASKINS WAY, SUITE 210
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
0
Stock Option (right to buy)
2.72
2023-07-19
4
A
0
20000
0.00
A
2033-07-18
Common Stock
20000
20000
D
The shares subject to such option vest in full on the earlier of (i) the one-year anniversary of the grant date or on (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.
/s/ Zed Zduniak, attorney-in-fact
2023-07-21